HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multinodular pseudolymphoma of the liver: computed tomography and magnetic resonance imaging findings.

Abstract
A 60-year-old woman who had had a history of renal cell carcinoma with intraperitoneal recurrence presented with multiple liver masses. Computed tomography demonstrated multiple enhancing lesions in the both lobes of the liver, and there was an apparent small vessel coursing within one of the lesions. On magnetic resonance imaging, masses showed slight T1 and T2 prolongation, and restricted diffusion: On the hepatobiliary phase of liver-specific contrast agent enhancement, lesions were shown as low signal intensity of varying degree. Liver metastases from renal cell carcinoma were suspected, and partial hepatectomy was performed for the superficially located nodules to make a definitive diagnosis. The final pathological diagnosis was reactive lymphoid hyperplasia or pseudolymphoma of the liver.
AuthorsAkinobu Osame, Ritsuko Fujimitsu, Mikiko Ida, Satoru Majima, Morishige Takeshita, Kengo Yoshimitsu
JournalJapanese journal of radiology (Jpn J Radiol) Vol. 29 Issue 7 Pg. 524-7 (Aug 2011) ISSN: 1867-108X [Electronic] Japan
PMID21882097 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA
Topics
  • Carcinoma, Renal Cell (diagnostic imaging, secondary, surgery)
  • Contrast Media
  • Diagnosis, Differential
  • Female
  • Gadolinium DTPA
  • Humans
  • Kidney Neoplasms (pathology, surgery)
  • Liver Diseases (diagnosis, diagnostic imaging, surgery)
  • Liver Function Tests
  • Liver Neoplasms (diagnostic imaging, secondary, surgery)
  • Magnetic Resonance Imaging (methods)
  • Middle Aged
  • Pseudolymphoma (diagnosis, diagnostic imaging, surgery)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: